Begin main content

Call for Patient Input and Clinical Experts: semaglutide

Published on: October 24, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name TBC
Generic name semaglutide
Manufacturer Novo Nordisk Canada Inc.
Indication(s) diabetes mellitus, type 2
Project Number SR0637-000
Call for patient input 2019-10-24
Patient input deadline 2019-12-12
Submit patient input Submit
Register as Clinical Expert Register